Introduction: A Home Hazard with Hidden Costs

Mould growth inside homes—especially in damp, poorly ventilated buildings—is more than just a maintenance or aesthetic problem. Recent research shows it contributes substantially to respiratory diseases, healthcare usage, and economic costs. Eliminating or significantly reducing mould exposure could save public healthcare systems millions, while improving quality of life, particularly for vulnerable populations.

Recent Study Insights: Quantifying the Burden

A modelling study (medRxiv 2025) used multistate lifetable methods to estimate health gains and financial savings from reducing moderate and severe indoor mould exposure. The findings include:

Lower rates of new asthma cases
Reduced severity in existing chronic respiratory diseases
Fewer lower respiratory tract infections
Gains in life years and quality of life

The model estimated that removing moderate mould exposure (16.5% of homes) and severe exposure (11.0%) would reduce disease incidence and ultimately reduce health system expenditure. While exact figures vary by region, savings run into millions per year when scaled across large populations.

Health Impacts: What Mould Exposure Does

Respiratory illnesses are the primary health effect linked to indoor mould:

Asthma: both new onset and exacerbations occur in mouldy homes.
Allergic rhinitis and other upper airway allergic responses.
Lower respiratory tract infections, especially among children and the elderly.

Mechanisms: How Mould Harms

Mould produces spores, volatile organic compounds (VOCs), and sometimes mycotoxins. These are inhaled, triggering:

Inflammation in airways
Immune responses driven by allergic sensitization
Potential colonization or infections in susceptible lungs

Moisture from leaks, poor insulation, condensation, and lack of ventilation create ideal conditions. Once mould colonizes surfaces, it becomes harder to remove and cleaning alone may not suffice unless the underlying moisture problem is addressed.

The costs are both direct (healthcare usage) and indirect (lost productivity, absenteeism, and long-term disability). Key cost drivers include:

More frequent GP visits, emergency department use, hospitalizations
Medication costs (e.g., inhalers, steroids)
Diagnostic costs

A UK-based assessment estimated thousands of DALYs lost annually due to mould and damp exposure. This represents not just immediate health costs, but long-term burden on health systems.

In addition, disadvantaged communities often face both higher exposure and less access to remediation, amplifying health inequities.

Policy Implications: Housing Matters

The data underscores that housing quality is a public health issue. Policy levers include:

Regulations requiring minimum standards for ventilation, insulation, moisture prevention
Incentives or subsidies for landlords/homeowners to remediate dampness and mould
Upfront investments in housing upgrades, justified by downstream healthcare savings
Cross-sector collaboration (health, housing, environment)

Challenges and Limitations

The modelled estimates depend on data quality: defining thresholds for “moderate” vs “severe” mould, and accounting for regional variation. In many countries, exposure data is patchy.

Behavioural factors (ventilation, cleaning habits, maintenance) are harder to model. There’s also a lag between housing improvements and health outcomes, complicating policy planning.

My Perspective: Prevention Over Cure

From a public health viewpoint, mould is a low-visibility but high-impact threat. We too often focus on treatment rather than prevention.

Investing in damp-free, ventilated, insulated homes is not only good policy—it’s cost-effective. Benefits include:

Reduced pressures on health systems
Improved school attendance for children
Fewer missed workdays
Healthier communities overall

Conclusion: Eradication Isn’t Idealistic—It’s Practical

The evidence is increasingly clear: mould isn’t just a nuisance; it’s a preventable cause of illness and cost. Eradicating (or significantly reducing) mould in homes would yield substantial health gains and cost savings.

For health systems, housing authorities, and policymakers, the imperative is clear: treat mould not just as a maintenance issue, but as a health priority.

References

World Health Organization. Asthma fact sheet.
Centers for Disease Control and Prevention (CDC). Respiratory infections.
medRxiv (2025). Modelling study on health gains from reducing indoor mould exposure.
Aspergillus spp., Penicillium spp., Cladosporium spp. — Wikipedia.

According to THE CONVERSATION